Transfusion Medicine (TM) is a relatively young medical discipline supporting a large number of medical specialties on an almost daily basis. In de routine of TM large amounts of data are collected and processed in a standardized way and depending on the economy of scale practiced. Blood and its components are not without risk when transfused. 

This paper discusses the interpretation of the measurement problem and Qbism in quantum mechanics using the Human Language based Consciousness (HLbC) model proposed by the author. The HLbC model holds that consciousness is generated from physical processes only. It adopts the position that consciousness is generated from physical processes only. 

The increasing prevalence of drug-resistant pathogens has highlighted the need for innovative approaches in drug discovery, including drug re-purposing. Artificial intelligence (AI) has emerged as a transformative tool in this endeavor, with the potential to revolutionize not only drug re-purposing for infectious diseases but also the field of hematology.

The HLbC model, as proposed by the author, has been utilized to interpret the varied behaviors manifested by individuals with split-brains. This paper initially provides a succinct overview of the function of the corpus callosum, pivotal to discussions concerning split-brains, along with the distinctive behaviors demonstrated by subjects with split-brains. Subsequently, it elucidates the application of the HLbC model in interpreting the behavior of such individuals. Comparative analyses with normal brain function are then conducted.

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide, and early diagnosis, treatment, and management are essential for reducing the burden of these diseases. This systematic review provides an update on recent developments in the field of CVDs, including the use of artificial intelligence (AI) in diagnosis and management, advances in genetic testing and precision medicine, the role of telemedicine and remote monitoring technologies, novel therapies such as gene therapy and cell therapy, and the importance of addressing mental health in the prevention and management of CVDs.